Financials

  • Market Capitalization 233.57 M
  • Employee 106
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.25
Rapporto prezzo/fatturato

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3558
AVXL
Anavex Life Sciences Corp. - Common Stock
2.43 USD+3.40%-7.95%-4.71%-78.68%225.19 M USD
3560
KPTI
Karyopharm Therapeutics Inc. - Common Stock
9.95 USD-1.00%+5.07%+3.11%+3.22%225.50 M USD
3580
OTLK
Outlook Therapeutics, Inc. - Common Stock
1.69 USD+9.03%+19.86%+28.03%+309.70%204.26 M USD
3587
DTIL
Precision BioSciences, Inc. - Common Stock
8.85 USD+3.03%-1.67%+43.20%+92.39%228.35 M USD